Search

everythinglearnresearchcommunity

for

Search:↓

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

More research is needed to understand how testosterone is maintained in adult males.

Nanocarriers can enhance cosmetics but face regulatory and safety challenges.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Platelet-rich plasma (PRP) is effective and safe for improving skin appearance.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

18β-glycyrrhetinic acid from licorice root is good for skin and hair treatments but has absorption challenges.

Many popular skincare products claim to prevent aging but lack strong evidence to prove their effectiveness and safety.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Topical imiquimod is as effective as 5-fluorouracil for treating actinic keratosis, with about a 5% risk of it turning into squamous cell carcinoma.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

PRP and cell therapies may help with hair loss, but more research is needed.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Finasteride can cause skin rash.

Iron deficiency might contribute to hair loss in women.